Search result for 'aspart'

Biocon Biologics partners with Civica Inc to increase affordability and access to Insulin Aspart in the US, targeting the 38.4 million Americans with diabetes.

Wockhardt has filed for marketing approval of its fast-acting insulin analog, Aspart injection, with the DCGI in India. This move aims to address the growing diabetes epidemic and provide patients...